Composition
Each ml contains:Buparvaquone 50mgFurosemide BP 55mgSorbitan mono oleate BP 100mg(as preservative) Oil base
Indications
For the treatment of theileriosis (east coastfever) particularly for advanced cases withpulmonary oedema Buparvaquone killstheilerial schizonts (in lymphoid cells) andpiroplasms (in red blood cells) and it suppressespreschizont stages during the incubationperiod of disease Buparvaquone kill theparasite through its actions on theirmitochondrial electron transport (respiratory)system. Furosemide is a diuretic, whichresolves pulmonary oedema.
Dosage & Administration
Injection by the Intramuscular routeinto the neck muscles at the rateof 1ml / 20 kg (2.5 mg per kg ofbuparvaquone and 2.75 mg/kg offurosemide) Repeat after 48 hours.In cases of exceptionally severeinfections with pulmonary oedema,further treatment at half the dosagerate may be required at 24 hour interval.
Withdrawal Period
From the last day of treatment:Milk for human consumption shouldnot be taken from animals treatedwith KenVaq Plus until at least 48hours after treatment.Milk for animals treated withKenVaq Plus is safe for consumptionby calves. Animals should not beslaughtered for human consumptionuntil at least 42 days after treatmentwith KenVaq Plus.
Precautions & Warnings
Localised swelling may occur at Injectionsites but it resolves in a few days.KenVaq Plus is very safe so overdosageis unlikely to cause significant adversee/ffect. KenVaq Plus must be administeredonly by the Intramuscular route. IntravenousInjection may cause severe shockKenVaq Plus is poorly mobilised aftersubcutaneous injection and its curativee/ffect is greatly reduced.Furosemide is chemically similar to thesulphonamides so KenVaq Plus should notbe used in animal with sulphonamidesensitivity
Storage
Store in a dry place, below 30°C, protectedfrom direct sunlight.Keep all medicines out of reach of children.
Presentation
50ml & 100ml